Amalgamated Bank’s Impax Laboratories, Inc. IPXL Stock Holding History

Amalgamated Bank’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,420	Closed	-$203K	–	1767
2018 Q1	$203K	Sell	10,420 -136	-1%	-$2.67K	0.01%	1450
2017 Q4	$176K	Buy	10,556 +653	+7%	+$12K	﹤0.01%	1525
2017 Q3	$201K	Buy	+9,903	New	+$189K	0.01%	1444
2016 Q4	–	Sell	-8,461	Closed	-$201K	–	1517
2016 Q3	$201K	Buy	+8,461	New	+$227K	0.01%	1271
2016 Q2	–	Sell	-7,551	Closed	-$242K	–	1416
2016 Q1	$242K	Buy	7,551 +664	+10%	+$23.3K	0.02%	1018
2015 Q4	$294K	Sell	6,887 -623	-8%	-$24.9K	0.04%	801
2015 Q3	$264K	Buy	7,510 +91	+1%	+$4.1K	0.03%	971
2015 Q2	$341K	Buy	+7,419	New	+$352K	0.03%	865

Amalgamated Bank's IPXL Position: Q2 2018 in Review

Amalgamated Bank sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 10,420 shares — an estimated $203K sold.

Amalgamated Bank first reported a position in IPXL in Q2 2015 and held it in 8 quarters. The position peaked at $341K in Q2 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Amalgamated Bank reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Amalgamated Bank sold 10,420 Impax Laboratories, Inc. shares in Q2 2018, an estimated $203K.
Amalgamated Bank first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 8 quarters.
Amalgamated Bank's Impax Laboratories, Inc. position peaked at $341K in Q2 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Amalgamated Bank's 13F filing for Q2 2018, filed 18 Jul 2018.